Blueshift Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Blueshift Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,017	Closed	-$242K	–	1061
2019 Q2	$242K	Sell	5,017 -3,875	-44%	-$204K	0.03%	615
2019 Q1	$557K	Buy	+8,892	New	+$611K	0.08%	372

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Blueshift Asset Management's BEAT Position: Q3 2019 in Review

Blueshift Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 5,017 shares — an estimated $242K sold.

Blueshift Asset Management first reported a position in BEAT in Q1 2019 and held it in 2 quarters. The position peaked at $557K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Blueshift Asset Management reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
Blueshift Asset Management sold 5,017 BioTelemetry, Inc. shares in Q3 2019, an estimated $242K.
Blueshift Asset Management first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 2 quarters.
Blueshift Asset Management's BioTelemetry, Inc. position peaked at $557K in Q1 2019.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Blueshift Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.